Avenue Therapeutics, Inc. (ATXI) Is At $3.98 Formed Wedge; 5 Bullish Analysts Covering Watts Water Technologies, Inc. (WTS)

January 13, 2018 - By Linda Rogers

Avenue Therapeutics, Inc. (ATXI) formed wedge down with $3.70 target or 7.00% below today’s $3.98 share price. Avenue Therapeutics, Inc. (ATXI) has $40.86 million valuation. The stock increased 4.19% or $0.16 during the last trading session, reaching $3.98. About 11,661 shares traded. Avenue Therapeutics, Inc. (NASDAQ:ATXI) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 11 analysts covering Watts Water Technologies (NYSE:WTS), 5 have Buy rating, 0 Sell and 6 Hold. Therefore 45% are positive. Watts Water Technologies had 24 analyst reports since August 17, 2015 according to SRatingsIntel. The company was maintained on Friday, May 5 by Oppenheimer. As per Thursday, August 3, the company rating was maintained by Boenning & Scattergood. The rating was maintained by Stifel Nicolaus with “Buy” on Sunday, October 15. The firm has “Hold” rating by Oppenheimer given on Wednesday, June 14. Stifel Nicolaus maintained it with “Buy” rating and $79.0 target in Friday, November 3 report. Stifel Nicolaus maintained it with “Buy” rating and $85.0 target in Sunday, December 10 report. The firm has “Neutral” rating by Goldman Sachs given on Wednesday, March 8. The firm earned “Hold” rating on Thursday, July 20 by Cowen & Co. Northcoast upgraded it to “Buy” rating and $79.0 target in Monday, September 18 report. The stock has “Hold” rating by Oppenheimer on Thursday, August 3. See Watts Water Technologies, Inc. (NYSE:WTS) latest ratings:

13/12/2017 Broker: Robert W. Baird Rating: Hold New Target: $78.0 Maintain
10/12/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $85.0 Maintain
03/11/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
03/11/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $79.0 Maintain
03/11/2017 Broker: Robert W. Baird Rating: Neutral Old Target: $71 New Target: $76 Maintain
02/11/2017 Broker: Boenning & Scattergood Rating: Buy Maintain
15/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $75.0 Maintain
04/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $71.0 Maintain
28/09/2017 Broker: Cowen & Co Rating: Hold New Target: $58.0 Maintain
18/09/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $72.0 Initiate

The stock increased 1.55% or $1.2 during the last trading session, reaching $78.65. About 66,609 shares traded. Watts Water Technologies, Inc. (NYSE:WTS) has risen 15.50% since January 13, 2017 and is uptrending. It has underperformed by 1.20% the S&P500.

Since August 25, 2017, it had 0 insider purchases, and 2 insider sales for $1.37 million activity. 15,803 shares were sold by Pagano Robert J Jr, worth $1.16 million. $205,323 worth of Watts Water Technologies, Inc. (NYSE:WTS) was sold by Melhem Elie.

Watts Water Technologies, Inc. designs, makes, and sells products and solutions that manage and conserve the flow of fluids and energy into, through and out of buildings in the residential and commercial markets. The company has market cap of $2.69 billion. It offers residential and commercial flow control products, including backflow preventers, water pressure regulators, temperature and pressure relief valves, and thermostatic mixing valves. It has a 29.13 P/E ratio. The firm also provides heating, ventilation, and air conditioning and gas products comprising commercial high-efficiency boilers, water heaters, and heating solutions; hydronic and electric heating systems for under-floor radiant applications; custom heat and hot water solutions; hydronic pump groups for boiler manufacturers and alternative energy control packages; and flexible stainless steel connectors for natural and liquid propane gas in commercial food service and residential applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>